Press release
Dry Powder Inhalation Expanding in Established Markets while Pursuing New Therapeutic Targets
(Amherst, NH) – Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. While several approaches for delivering active substances via oral inhalation compete in this space, dry powder inhalation (DPI) continues to attract investment in new combination product development and therapeutic indications at the expense of more established methods such as metered dose inhalers and nebulizers.The rising potential of dry powder inhalation is being driven by research activity in powder formulations, advances in particle engineering, and the development of novel device architectures. The combination of improved particle properties and more efficient inhaler designs is creating new opportunities for dry powder inhalation and expanding the range of active compounds that can be effectively delivered to the lung via DPI.
“As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies, inhaled medicine is increasingly being viewed as patient-friendly and cost-effective,” explains George Perros, Greystone Research Managing Director. “Our analysis demonstrates that inhaled administration in general, and DPI in particular, are well positioned to take advantage of these trends and evolve into a significant factor in the future of pharmaceutical development and the commercialization of therapeutic drugs.”
These findings are contained in a new and comprehensive report, researched and prepared by Greystone Research Associates. Dry Powder Inhalation: Advancing Technology, Evolving Devices, Emerging Opportunities contains product and device assessments, pipeline analysis, market data, company profiles, forecasts and detailed analysis of key technology, regulatory and business factors.
More information is available at www.greystoneassociates.org .
Source: Greystone Research Associates
About Greystone
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dry Powder Inhalation Expanding in Established Markets while Pursuing New Therapeutic Targets here
News-ID: 160671 • Views: …
More Releases from Greystone Research Associates
Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend patent rights protection. While reformulation has been and is an important approach, efforts to prolong IP benefits have only recently involved IV-to-SC drug re-engineering. This migration…
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace the current generation of antibiotics is complicated by the methods that bacteria have acquired to evade attempts to destroy them – methods often referred to a virulence factors.
A microorganism can possess a wide array of virulence factors. They may only express these virulence factors when…
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device innovations such as noninvasive glucose monitoring, the potential of the technology has yet to be realized due to the inability to solve the issues of reliable product performance from unit to unit and across a wide user population.
To fully address the unmet need these technologies…
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and …
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. There approaches have attracted a growing number of drug developers anxious to profit from…
More Releases for DPI
Deep Packet Inspection (DPI) Market 2021 | Detailed Report
Deep Packet Inspection (DPI) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Deep Packet Inspection (DPI) Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644215
The report provides a comprehensive analysis of company profiles listed below:
- Cisco Systems
-…
United States Vaccines Market - Exclusive Report by DPI Research
The latest study released on the United States Vaccines Market by DPI Research evaluates market size, trend, and forecast to 2027. The United States Vaccines Market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Download Report…
DPI in Packet Switched Networks
Deep packet inspection (DPI) is an advanced monitoring technique and a useful application for telcos. The main advantage of DPI is that it provides most accurate information on bandwidth as it reads the packet content. Analyzing digital traffic can reveal some very useful insights and help telcos to identify general consumer behaviour. For instance, how long customers stay at a location, how often is a customer joining a specific location,…
Deep Packet Inspection (DPI) Market -
According to a new research report, titled ‘Deep Packet Inspection (DPI) Market - Global Industry Analysis, Size, Share and Forecast 2012 - 2018’, published by Transparency Market Research, the global deep packet inspection market is expected to grow and reach a market value of US$3.8 bn by 2018 from a value of US$0.5 bn in 2012. Overall, the market is estimated to display a CAGR of 36.6% in the forecast…
DPI Research Published a New Report on Seasonal Influenza Vaccine Market
Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.
Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size…
DPI Research - Leading Market Research Firm
DPI Research is a market research, social research and marketing company which delivers all the information required to solve business and marketing problems. DPI Research is a business solutions firm which offer bespoke syndicated research reports, custom research solutions, marketing services and social research across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to…
